Frequency Therapeutics logo
Frequency Therapeutics FREQ
$ 14.98 0.0%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Frequency Therapeutics Financial Statements 2011-2024 | FREQ

Annual Financial Statements Frequency Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

22.9 M 158 K 178 M 1.32 B 205 M - - - - - - - -

Shares

1.53 M 255 K 34.6 M 33.8 M 8.65 M - - - - - - - -

Historical Prices

15 0.62 5.13 35.3 17.5 - - - - - - - -

Net Income

-81.2 M -58 M -84.7 M -26.5 M -18.7 M -19.2 M -20.2 M - - - - - -

Revenue

- - 14.1 M 37 M 28.9 M - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - 37 M - - - - - - - - -

Operating Income

-84.5 M -59 M -84 M -27.6 M -20.7 M -18.9 M -16.3 M - - - - - -

Interest Expense

3.39 M 976 K 764 K - 1.78 M -106 K -174 K - - - - - -

EBITDA

-80.9 M -56.5 M -81.3 M -26.8 M -19.9 M -18.3 M -12 M - - - - - -

Operating Expenses

84.5 M 59 M 98.1 M 64.5 M 49.6 M - - - - - - - -

General and Administrative Expenses

27.3 M 16.8 M 37.2 M 27.1 M 30.8 M 7.06 M 4.34 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Frequency Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

9.3 M 8.99 M 8.02 M 8.02 M 284 K 276 K 272 K 35.3 M 35.2 M 35 M 34.8 M 34.6 M 34.4 M 34.2 M 34.1 M 34 M 33.1 M 31.1 M 30.9 M 30.8 M 2.16 M 2.01 M 1.8 M 2.08 M 1.58 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-21 M -21.8 M -19.6 M - -18.5 M -17.6 M -19.6 M - -19.5 M -21.3 M -23.4 M - -25.2 M -17.7 M -20.4 M -10.2 M -5.34 M -6.02 M -4.91 M -5.49 M -575 K -6.85 M -5.83 M -5.45 M -5.14 M -4.44 M -4.15 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - 9.42 M 4.65 M 9.95 M 11.2 M 8.52 M 7.26 M 4.71 M 24.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-23.3 M -24.1 M -21.5 M - -19.1 M -18.4 M -20.1 M - -20.3 M -21.3 M -23.3 M - -25 M -17.5 M -20.2 M - -5.42 M -6.2 M -5.66 M - -1.25 M -7.02 M -5.92 M - -5.06 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

2.28 M 2.33 M 1.91 M - 656 K 786 K 481 K - 263 K 208 K 178 K - 182 K 182 K 218 K - - - - - - - - - 63 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -20.7 M - -18.8 M -17.9 M -19.3 M - -19.6 M -20.6 M -22.5 M - -24.3 M -16.6 M -19.8 M - -5.12 M -5.96 M -5.44 M - -1.04 M -6.89 M -5.75 M - -4.91 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

23.3 M 24.1 M 21.5 M - 19.1 M 18.4 M 20.1 M - 20.3 M 21.3 M 23.3 M - 25 M 26.9 M 24.8 M - 16.7 M 14.7 M 12.9 M - 25.5 M 7.02 M 5.92 M - 5.06 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

7.33 M 6.99 M 7.88 M - 5.14 M 5.28 M 5.39 M - 8.56 M 8 M 9.48 M - 9.33 M 9.5 M 9.74 M - 6.51 M 5.96 M 6.25 M - 4.27 M 3.1 M 2.47 M - 1.51 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency